Microbot Medical Inc. (MBOT) vs Nyxoah SA (NYXH)

Microbot Medical Inc. and Nyxoah SA are both Medical Instruments & Supplies companies. Nyxoah SA is the larger, with a market value of $121.2M against $63.8M — 1.9× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −59.1%. Nyxoah SA has the higher net margin (−446.4% vs −3,955.2%) and the higher return on invested capital (−117.8% vs −850.5%). Across the 18 metrics below, Nyxoah SA leads on 10 and Microbot Medical Inc. on 8.

Valuation

Metric MBOT NYXH Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 154.46 2.52 2.52
P/B 0.93 0.65 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA 0.06 n/m 14.62
EV/Sales (2.87) 0.75 2.88
Earnings yield (25.26%) (227.03%) (2.67%)
Free cash flow yield (28.10%) (136.70%) 0.09%

Profitability

Metric MBOT NYXH Medical Instruments & Supplies median
Gross margin (166.30%) 60.16% 54.29%
Operating margin (4,480.03%) (391.25%) 1.07%
Net margin (3,955.22%) (446.39%) (1.61%)
Free cash flow margin (4,340.11%) (344.99%) 1.08%
Return on equity (32.91%) (124.41%) (1.32%)
Return on assets (30.68%) (68.23%) 0.00%
Return on invested capital (850.51%) (117.82%) 0.00%

Growth

Metric MBOT NYXH Medical Instruments & Supplies median
Revenue growth (TTM) (59.09%) 366.24% 8.85%
EPS growth (last fiscal year) 60.27% (36.22%) 8.65%
Revenue growth, 5-year CAGR 0.39% 170.14% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBOT NYXH Medical Instruments & Supplies median
Debt to equity 0.00 0.72 0.10
Current ratio 18.56 2.38 2.48
Net debt to EBITDA 5.35 0.08 0.89

Dividend

Metric MBOT NYXH Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric MBOT NYXH Medical Instruments & Supplies median
Market cap 63.80m 121.19m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack